新发心力衰竭后死亡率的长期趋势与模式:86 000 例纵向分析
该研究基于英国临床实践研究数据链,分析 2002 至 2013 年新诊断心衰患者的 1 年死亡率。全因死亡率仅小幅下降(RR 0.94),心血管死亡率下降(RR 0.73)但被非心血管死亡增加(RR 1.22)抵消;80 岁以下患者死亡率下降(RR 0.79),80 岁以上无显著变化。
要点
- 新发心衰后全因死亡率下降有限,心血管死亡减少被非心血管死亡增加抵消。
- 80 岁以下患者全因死亡率显著下降,80 岁以上患者无显著改善。
- 2013 年非心血管死亡增加主要归因于呼吸系统疾病和感染。
核心结论
- 新发心衰患者中,年轻和中年患者死亡率及所有年龄组心血管死亡率均有改善,但非心血管事件的高发和增加阻碍了整体死亡率的改善。
研究设计与样本
- 基于英国临床实践研究数据链的群体回顾性队列研究,纳入 2002 年 1 月至 2013 年 12 月新诊断心衰的 86 833 例患者,随访至 2014 年 12 月。
主要发现
- 2013 年与 2002 年相比,全因死亡率比值比(RR)为 0.94(95%CI 0.88-1.00),心血管死亡 RR 为 0.73(95%CI 0.67-0.80),非心血管死亡 RR 为 1.22(95%CI 1.11-1.33)。
- 80 岁以下患者全因死亡率 RR 为 0.79(95%CI 0.71-0.88),80 岁以上患者 RR 为 0.97(95%CI 0.90-1.06)。
- 2013 年死因中心血管原因占 898 例(43%),肿瘤 311 例(15%),呼吸系统疾病 243 例(12%),感染占 13%。
临床怎么用
- 心衰管理除关注心血管死亡外,应重视非心血管合并症,特别是感染预防和呼吸系统疾病管理,以进一步改善预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite considerable improvements in heart failure care, mortality rates among patients in high-income countries have changed little since the early 2000s. Understanding the reasons underlying these trends may provide valuable clues for developing more targeted therapies and public health strategies. OBJECTIVE: To investigate mortality rates following a new diagnosis of heart failure and examine changes over time and by cause of death and important patient features. DESIGN, SETTING, AND PARTICIPANTS: This population-based retrospective cohort study analyzed anonymized electronic health records of individuals who received a new diagnosis of heart failure between January 2002 and December 2013 who were followed up until December 2014 from the Clinical Practice Research Datalink, which links information from primary care, secondary care, and the national death registry from a subset of the UK population. The data were analyzed from January 2018 to February 2019. MAIN OUTCOMES AND MEASURES: All-cause and cause-specific mortality rates at 1 year following diagnosis. Poisson regression models were used to calculate rate ratios (RRs) and 95% confidence intervals comparing 2013 with 2002, adjusting for age, sex, region, socioeconomic status, and 17 major comorbidities. RESULTS: Of 86 833 participants, 42 581 (49%) were women, 51 215 (88%) were white, and the mean (SD) age was 76.6 (12.6) years. While all-cause mortality rates declined only modestly over time (RR comparing 2013 with 2002, 0.94; 95% CI, 0.88-1.00), underlying patterns presented explicit trends. A decline in cardiovascular mortality (RR, 0.73; 95% CI, 0.67-0.80) was offset by an increase in noncardiovascular deaths (RR, 1.22; 95% CI, 1.11-1.33). Subgroup analyses further showed that overall mortality rates declined among patients younger than 80 years (RR, 0.79; 95% CI, 0.71-0.88) but not among those older than 80 years (RR, 0.97; 95% CI, 0.90-1.06). After cardiovascular causes (898 [43%]), the major causes of death in 2013 were neoplasms (311 [15%]), respiratory conditions (243 [12%]), and infections (13%), the latter 2 explaining most of the observed increase in noncardiovascular mortality. CONCLUSIONS AND RELEVANCE: Among patients with a new heart failure diagnosis, considerable progress has been achieved in reducing mortality in young and middle-aged patients and cardiovascular mortality across all age groups. Improvements to overall mortality are hindered by high and increasing rates of noncardiovascular events. These findings challenge current research priorities and management strategies and call for a greater emphasis on associated comorbidities. Specifically, infection prevention presents as a major opportunity to improve prognosis.
引用
- Conrad N, Judge A, Canoy D, et al. Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 Individuals. JAMA Cardiol. 2019. PMID: 31479100. doi:10.1001/jamacardio.2019.3593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。